Back to News
Market Impact: 0.35
Insulet Q3 Net Income Rises; Issues FY26 Outlook
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Insulet reported third-quarter net income of $141.1 million, or $2.03 per diluted share, up from $87.6 million, or $1.24 per diluted share, a year earlier. Adjusted net income increased 57.2% to $138.0 million from $87.8 million; the article text is truncated before providing further results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
PODD0.70
More News
- TD Cowen raises Insulet stock price target to $163 on Omnipod strength
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- ‘Seismic’ blue wave triggers the sinking of oil prices, energy stocks, and the chances of power permitting reform
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT
- Nifty Bounces Back to Beat All of Asia on Foreign Flows, Earnings
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- Weekly Update: Sector Analysis, Improvements on Research Data, and Performance Enhancements
- How to Automate Equity Research Workflows: A Control-First Guide